Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

SMX vs IDAI vs COHU vs ACXP

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SMX
SMX (Security Matters) Public Limited Company

Specialty Business Services

IndustrialsNASDAQ • IE
Market Cap$497.00
5Y Perf.-100.0%
IDAI
T Stamp Inc.

Software - Application

TechnologyNASDAQ • US
Market Cap$3M
5Y Perf.-99.2%
COHU
Cohu, Inc.

Semiconductors

TechnologyNASDAQ • US
Market Cap$2.23B
5Y Perf.+24.7%
ACXP
Acurx Pharmaceuticals, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$5M
5Y Perf.-97.5%

SMX vs IDAI vs COHU vs ACXP — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SMX logoSMX
IDAI logoIDAI
COHU logoCOHU
ACXP logoACXP
IndustrySpecialty Business ServicesSoftware - ApplicationSemiconductorsBiotechnology
Market Cap$497.00$3M$2.23B$5M
Revenue (TTM)$0.00$4M$481M$0.00
Net Income (TTM)$-4M$-12M$-56M$-7.97B
Gross Margin60.0%25.7%
Operating Margin-183.3%-10.6%
Forward P/E89.2x
Total Debt$6M$4M$359M$0.00
Cash & Equiv.$2M$3M$227M$7.56B

SMX vs IDAI vs COHU vs ACXPLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SMX
IDAI
COHU
ACXP
StockDec 21May 26Return
SMX (Security Matte… (SMX)1000.0-100.0%
T Stamp Inc. (IDAI)1000.8-99.2%
Cohu, Inc. (COHU)100124.7+24.7%
Acurx Pharmaceutica… (ACXP)1002.5-97.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: SMX vs IDAI vs COHU vs ACXP

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: COHU leads in 3 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. SMX (Security Matters) Public Limited Company is the stronger pick specifically for operational efficiency and capital deployment. IDAI also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
SMX
SMX (Security Matters) Public Limited Company
The Niche Pick

SMX is the #2 pick in this set and the best alternative if efficiency is your priority.

  • -2.8% ROA vs ACXP's -413.5%
Best for: efficiency
IDAI
T Stamp Inc.
The Income Pick

IDAI is the clearest fit if your priority is income & stability.

  • beta 1.99
  • Beta 1.99 vs SMX's 4.47
Best for: income & stability
COHU
Cohu, Inc.
The Growth Play

COHU carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 12.7%, EPS growth -6.7%, 3Y rev CAGR -17.7%
  • 330.2% 10Y total return vs SMX's 12.0%
  • Lower volatility, beta 2.13, Low D/E 45.8%, current ratio 6.88x
  • Beta 2.13, current ratio 6.88x
Best for: growth exposure and long-term compounding
ACXP
Acurx Pharmaceuticals, Inc.
The Secondary Option

ACXP lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
See the full category breakdown
CategoryWinnerWhy
GrowthCOHU logoCOHU12.7% revenue growth vs IDAI's -32.4%
Quality / MarginsCOHU logoCOHU-11.5% margin vs IDAI's -316.4%
Stability / SafetyIDAI logoIDAIBeta 1.99 vs SMX's 4.47
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)COHU logoCOHU+199.7% vs SMX's -100.0%
Efficiency (ROA)SMX logoSMX-2.8% ROA vs ACXP's -413.5%

SMX vs IDAI vs COHU vs ACXP — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SMXSMX (Security Matters) Public Limited Company

Segment breakdown not available.

IDAIT Stamp Inc.
FY 2024
Professional Services (Over Time)
72.5%$2M
License Fees (Over Time)
27.5%$573,000
COHUCohu, Inc.
FY 2014
Semiconductor Equipment
95.0%$317M
Microwave Communications Equipment
5.0%$17M
ACXPAcurx Pharmaceuticals, Inc.

Segment breakdown not available.

SMX vs IDAI vs COHU vs ACXP — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCOHULAGGINGACXP

Income & Cash Flow (Last 12 Months)

COHU leads this category, winning 3 of 6 comparable metrics.

COHU and ACXP operate at a comparable scale, with $481M and $0 in trailing revenue. Profitability is closely matched — net margins range from -11.5% (COHU) to -3.2% (IDAI). On growth, IDAI holds the edge at +70.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSMX logoSMXSMX (Security Mat…IDAI logoIDAIT Stamp Inc.COHU logoCOHUCohu, Inc.ACXP logoACXPAcurx Pharmaceuti…
RevenueTrailing 12 months$0$4M$481M$0
EBITDAEarnings before interest/tax-$4M-$6M-$11M$35,910
Net IncomeAfter-tax profit-$4M-$12M-$56M-$8.0B
Free Cash FlowCash after capex-$1M-$8M$32M$4.6B
Gross MarginGross profit ÷ Revenue+60.0%+25.7%
Operating MarginEBIT ÷ Revenue-183.3%-10.6%
Net MarginNet income ÷ Revenue-3.2%-11.5%
FCF MarginFCF ÷ Revenue-2.2%+6.6%
Rev. Growth (YoY)Latest quarter vs prior year+70.7%+29.3%
EPS Growth (YoY)Latest quarter vs prior year-647.6%+32.1%+60.6%+98.2%
COHU leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — SMX and IDAI and COHU each lead in 1 of 3 comparable metrics.
MetricSMX logoSMXSMX (Security Mat…IDAI logoIDAIT Stamp Inc.COHU logoCOHUCohu, Inc.ACXP logoACXPAcurx Pharmaceuti…
Market CapShares × price$497$3M$2.2B$5M
Enterprise ValueMkt cap + debt − cash$4M$4M$2.4B-$7.6B
Trailing P/EPrice ÷ TTM EPS0.00x-0.22x-29.86x-0.40x
Forward P/EPrice ÷ next-FY EPS est.89.21x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple
Price / SalesMarket cap ÷ Revenue0.89x4.93x
Price / BookPrice ÷ Book value/share0.00x0.86x2.82x0.00x
Price / FCFMarket cap ÷ FCF207.83x
Evenly matched — SMX and IDAI and COHU each lead in 1 of 3 comparable metrics.

Profitability & Efficiency

SMX leads this category, winning 4 of 9 comparable metrics.

SMX delivers a -3.0% return on equity — every $100 of shareholder capital generates $-3 in annual profit, vs $-6 for ACXP. SMX carries lower financial leverage with a 0.27x debt-to-equity ratio, signaling a more conservative balance sheet compared to IDAI's 1.30x. On the Piotroski fundamental quality scale (0–9), COHU scores 4/9 vs IDAI's 1/9, reflecting mixed financial health.

MetricSMX logoSMXSMX (Security Mat…IDAI logoIDAIT Stamp Inc.COHU logoCOHUCohu, Inc.ACXP logoACXPAcurx Pharmaceuti…
ROE (TTM)Return on equity-3.0%-189.5%-6.8%-6.0%
ROA (TTM)Return on assets-2.8%-105.4%-4.9%-4.1%
ROICReturn on invested capital-40.5%-2.2%-5.7%
ROCEReturn on capital employed-60.1%-194.9%-5.9%
Piotroski ScoreFundamental quality 0–93143
Debt / EquityFinancial leverage0.27x1.30x0.46x
Net DebtTotal debt minus cash$4M$1M$132M-$7.6B
Cash & Equiv.Liquid assets$2M$3M$227M$7.6B
Total DebtShort + long-term debt$6M$4M$359M$0
Interest CoverageEBIT ÷ Interest expense-1.24x-22.08x-168.82x
SMX leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

COHU leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in COHU five years ago would be worth $12,218 today (with dividends reinvested), compared to $0 for SMX. Over the past 12 months, COHU leads with a +199.7% total return vs SMX's -100.0%. The 3-year compound annual growth rate (CAGR) favors COHU at 12.1% vs SMX's -99.0% — a key indicator of consistent wealth creation.

MetricSMX logoSMXSMX (Security Mat…IDAI logoIDAIT Stamp Inc.COHU logoCOHUCohu, Inc.ACXP logoACXPAcurx Pharmaceuti…
YTD ReturnYear-to-date-98.8%-38.4%+92.9%-23.2%
1-Year ReturnPast 12 months-100.0%+20.9%+199.7%-70.1%
3-Year ReturnCumulative with dividends-100.0%-87.5%+40.7%-96.5%
5-Year ReturnCumulative with dividends-100.0%-99.1%+22.2%-98.7%
10-Year ReturnCumulative with dividends+1200.0%+102.4%+330.2%-98.7%
CAGR (3Y)Annualised 3-year return-99.0%-50.0%+12.1%-67.4%
COHU leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — IDAI and COHU each lead in 1 of 2 comparable metrics.

IDAI is the less volatile stock with a 1.99 beta — it tends to amplify market swings less than SMX's 4.47 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. COHU currently trades 93.7% from its 52-week high vs SMX's 0.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSMX logoSMXSMX (Security Mat…IDAI logoIDAIT Stamp Inc.COHU logoCOHUCohu, Inc.ACXP logoACXPAcurx Pharmaceuti…
Beta (5Y)Sensitivity to S&P 5004.47x1.99x2.13x2.42x
52-Week HighHighest price in past year$20528.69$5.28$50.68$21.00
52-Week LowLowest price in past year$1.02$1.80$15.34$1.33
% of 52W HighCurrent price vs 52-week peak+0.0%+47.2%+93.7%+10.1%
RSI (14)Momentum oscillator 0–10030.149.175.540.9
Avg Volume (50D)Average daily shares traded2.8M43K953K3.6M
Evenly matched — IDAI and COHU each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricSMX logoSMXSMX (Security Mat…IDAI logoIDAIT Stamp Inc.COHU logoCOHUCohu, Inc.ACXP logoACXPAcurx Pharmaceuti…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$49.75
# AnalystsCovering analysts14
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+2.1%+0.3%+100.0%
Insufficient data to determine a leader in this category.
Key Takeaway

COHU leads in 2 of 6 categories (Income & Cash Flow, Total Returns). SMX leads in 1 (Profitability & Efficiency). 2 tied.

Best OverallCohu, Inc. (COHU)Leads 2 of 6 categories
Loading custom metrics...

SMX vs IDAI vs COHU vs ACXP: Key Questions Answered

8 questions · data-driven answers · updated daily

01

Is SMX or IDAI or COHU or ACXP a better buy right now?

For growth investors, Cohu, Inc.

(COHU) is the stronger pick with 12. 7% revenue growth year-over-year, versus -32. 4% for T Stamp Inc. (IDAI). Analysts rate Cohu, Inc. (COHU) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — SMX or IDAI or COHU or ACXP?

Over the past 5 years, Cohu, Inc.

(COHU) delivered a total return of +22. 2%, compared to -100. 0% for SMX (Security Matters) Public Limited Company (SMX). Over 10 years, the gap is even starker: SMX returned +1200% versus ACXP's -98. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — SMX or IDAI or COHU or ACXP?

By beta (market sensitivity over 5 years), T Stamp Inc.

(IDAI) is the lower-risk stock at 1. 99β versus SMX (Security Matters) Public Limited Company's 4. 47β — meaning SMX is approximately 125% more volatile than IDAI relative to the S&P 500. On balance sheet safety, SMX (Security Matters) Public Limited Company (SMX) carries a lower debt/equity ratio of 27% versus 130% for T Stamp Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — SMX or IDAI or COHU or ACXP?

By revenue growth (latest reported year), Cohu, Inc.

(COHU) is pulling ahead at 12. 7% versus -32. 4% for T Stamp Inc. (IDAI). On earnings-per-share growth, the picture is similar: SMX (Security Matters) Public Limited Company grew EPS 94. 3% year-over-year, compared to -6. 7% for Cohu, Inc.. Over a 3-year CAGR, IDAI leads at -5. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — SMX or IDAI or COHU or ACXP?

SMX (Security Matters) Public Limited Company (SMX) is the more profitable company, earning 0.

0% net margin versus -344. 1% for T Stamp Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SMX leads at 0. 0% versus -303. 9% for IDAI. At the gross margin level — before operating expenses — IDAI leads at 65. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — SMX or IDAI or COHU or ACXP?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is SMX or IDAI or COHU or ACXP better for a retirement portfolio?

For long-horizon retirement investors, SMX (Security Matters) Public Limited Company (SMX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1200% 10Y return).

Acurx Pharmaceuticals, Inc. (ACXP) carries a higher beta of 2. 42 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SMX: +1200%, ACXP: -98. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between SMX and IDAI and COHU and ACXP?

These companies operate in different sectors (SMX (Industrials) and IDAI (Technology) and COHU (Technology) and ACXP (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

SMX

Quality Business

  • Sector: Industrials
  • Market Cap > $500M
Run This Screen
Stocks Like

IDAI

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 35%
  • Gross Margin > 35%
Run This Screen
Stocks Like

COHU

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Gross Margin > 15%
Run This Screen
Stocks Like

ACXP

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.